Chief Executive Officer, Crescendo Biologics Ltd
Peter Pack has 25 years of experience in the successful establishment and growth of international life science companies. For 18 years, he was CEO and Managing Director of product-oriented companies ranging from early stage up to international commercialization and profitability with several thousand certified products; predominantly working in Germany, the UK and Poland. He raised over € 125 m in venture capital, worked on several Boards and headed companies with up to 400 employees.
He started his career in the initial team of MorphoSys AG (1993-1999) as co-inventor of the commercially most successful phage library and was co-founder and CEO of the cancer diagnostics company mtm laboratories (1999-2008). The companies for which Peter worked in central positions were either successfully sold (mtm laboratories, Polytech Ophthalmologie, Signature Diagnostics), highly profitable (LGC Standards, Polytech) and/or went public (MorphoSys AG).
Peter started in Crescendo initially as VC and took over the CEO role 3 years ago to execute the transition of a transgenic platform provider to a developer of differentiated, multispecific biologics. Since then, the company has established a pipeline with a novel T-Cell engager mechanism and a collaboration with Takeda Pharma in the Oncology field.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557